Cargando…

Association between high-mobility group box 2 and subclinical hypertension-mediated organ damage in young adults

BACKGROUND: Hypertension-mediated organ damage (HMOD) is an emerging problem among young adults. The potential role of chronic immune-mediated inflammation in the pathogenesis of HMOD is increasingly being recognized. High-mobility group box 2 (HMGB2) is known for its role in the modulation of innat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Jindong, Liu, Gang, Xia, Siwei, Liu, Sen, Yang, Yi, Wang, Dan, Hou, Jixin, Dai, Xiaozhen, Zhou, Peng, Wang, Peijian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661567/ https://www.ncbi.nlm.nih.gov/pubmed/36387760 http://dx.doi.org/10.1177/20406223221135011

Ejemplares similares

Feasibility and effectiveness of a single-catheter approach for adrenal vein sampling in patients with primary aldosteronism
por: Wan, Jindong, et al.
Publicado: (2021)

Dietary chlorogenic acid ameliorates oxidative stress and improves endothelial function in diabetic mice via Nrf2 activation
por: Wang, Dan, et al.
Publicado: (2021)

Case report: Percutaneous adrenal arterial embolization cures resistant hypertension
por: Zhou, Yaqiong, et al.
Publicado: (2022)

Renal denervation in a patient with a highly tortuous renal artery using a guide extension catheter: a case report
por: Wang, Peijiang, et al.
Publicado: (2021)

Involvement of High Mobility Group Box 1 Protein in Optic Nerve Damage in Diabetes
por: Mohammad, Ghulam, et al.
Publicado: (2022)

The role of high mobility group box 1 protein in acute cerebrovascular diseases
por: Mu, Shu-Wen, et al.
Publicado: (2018)

Prognostic value of the high-mobility group box-1 in young patients with chest pain
por: Haghjooy-Javanmard, Shaghayegh, et al.
Publicado: (2014)

The relationship of endothelial function and arterial stiffness with subclinical target organ damage in essential hypertension
por: Sun, Yancui, et al.
Publicado: (2022)

High-mobility group box 1 protein, angiotensins, ACE2, and target organ damage
por: Luft, Friedrich C.
Publicado: (2015)

High-Mobility Group Box 1 Induces Calcineurin-Mediated Cell Hypertrophy in Neonatal Rat Ventricular Myocytes
por: Su, Fei-fei, et al.
Publicado: (2012)

From Inflammation to Fibrosis: Novel Insights into the Roles of High Mobility Group Protein Box 1 in Schistosome-Induced Liver Damage
por: Zhong, Haoran, et al.
Publicado: (2022)

Impact of Serum High Mobility Group Box 1 and Soluble Receptor for Advanced Glycation End-Products on Subclinical Atherosclerosis in Patients with Granulomatosis with Polyangiitis
por: de Souza, Alexandre W. S., et al.
Publicado: (2014)

A Nuclear Factor of High Mobility Group Box Protein in Toxoplasma gondii
por: Wang, Hui, et al.
Publicado: (2014)

High-Mobility Group Box 1 Inhibitor BoxA Alleviates Neuroinflammation-Induced Retinal Ganglion Cell Damage in Traumatic Optic Neuropathy
por: Peng, Jingyi, et al.
Publicado: (2022)

Subclinical Hypertension-Mediated Organ Damage (HMOD) in Hypertension: Atherosclerotic Cardiovascular Disease (ASCVD) and Calcium Score
por: Rizzoni, Damiano, et al.
Publicado: (2022)

Association of uric acid in serum and urine with subclinical renal damage: Hanzhong Adolescent Hypertension Study
por: Wang, Yang, et al.
Publicado: (2019)

Efficacy of an Internet-Based Intervention for Subclinical Depression (MoodBox) in China: Study Protocol for a Randomized Controlled Trial
por: Chen, Xu, et al.
Publicado: (2021)

Identification and Characterization of the Lamprey High-Mobility Group Box 1 Gene
por: Pang, Yue, et al.
Publicado: (2012)

High-mobility group box 1: role in ARDS
por: Ishizaka, A, et al.
Publicado: (2005)

High‐Mobility Group Box‐1 and Liver Disease
por: Gaskell, Harriet, et al.
Publicado: (2018)

High mobility group box 1 in diabetic nephropathy
por: Shi, Haitao, et al.
Publicado: (2017)

High Mobility Group Box 1 in Human Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

High Mobility Group Box-1 and Blood–Brain Barrier Disruption
por: Nishibori, Masahiro, et al.
Publicado: (2020)

Intensity of hypertensive exposure in young adulthood and subclinical atherosclerosis in middle age: Evidence from the CARDIA study
por: Xiong, Zhenyu, et al.
Publicado: (2022)

Cerebral Small Vessel Disease Associated with Subclinical Vascular Damage Indicators in Asymptomatic Hypertensive Patients
por: Hernández-Díaz, Zenaida Milagros, et al.
Publicado: (2019)

Enhancing regulatory T-cell function via inhibition of high mobility group box 1 protein signaling in immune thrombocytopenia
por: Wang, Haoyi, et al.
Publicado: (2022)

Baicalin Inhibits Haemophilus Parasuis-Induced High-Mobility Group Box 1 Release during Inflammation
por: Fu, Shulin, et al.
Publicado: (2018)

Cardiac Nuclear High-Mobility Group Box 1 Ameliorates Pathological Cardiac Hypertrophy by Inhibiting DNA Damage Response
por: Takahashi, Tetsuya, et al.
Publicado: (2019)

Role of high-mobility group box 1 in methamphetamine-induced activation and migration of astrocytes
por: Zhang, Yuan, et al.
Publicado: (2015)

Vagal modulation of high mobility group box-1 protein mediates electroacupuncture-induced cardioprotection in ischemia-reperfusion injury
por: Zhang, Juan, et al.
Publicado: (2015)

Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats
por: Yang, Pil-Sung, et al.
Publicado: (2014)

The association between high mobility group box 1 chromatin protein and mitotic chromosomes in glioma cells
por: Jia, Liyun, et al.
Publicado: (2020)

Elevation of High-Mobility Group Protein Box-1 in Serum Correlates with Severity of Acute Intracerebral Hemorrhage
por: Zhou, Yu, et al.
Publicado: (2010)

Toxoplasma gondii Infection Induces High Mobility Group Box 1 Released from Mouse Macrophages
por: Wang, Hui, et al.
Publicado: (2017)

Relationship between plasma high mobility group box-1 protein levels and clinical outcomes of aneurysmal subarachnoid hemorrhage
por: Zhu, Xiang-Dong, et al.
Publicado: (2012)

Clinical and prognostic significance of high-mobility group box-1 in human gliomas
por: WANG, XIN-JUN, et al.
Publicado: (2015)

High mobility group box 1: as a 'testament' mediator
por: Maruyama, I, et al.
Publicado: (2005)

The Role of High Mobility Group Box 1 in Innate Immunity
por: Lee, Shin-Ae, et al.
Publicado: (2014)

High Mobility Group Box Protein-1 in Wound Repair
por: Ranzato, Elia, et al.
Publicado: (2012)

High-Mobility Group Box 1 in Dry Eye Inflammation
por: Lema, Carolina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v0ve5vus5t75ph14ls0r1jjqno